Global Multiple Sclerosis (MS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035
Global Multiple Sclerosis (MS) Market Outlook Thelansis’s “Global Multiple Sclerosis (MS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035″ covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Multiple Sclerosis treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Global Multiple Sclerosis (MS) Overview Multiple sclerosis (MS) is a chronic, immune-mediated, demyelinating, and neurodegenerative disease of the central nervous system (CNS) fundamentally driven by autoreactive T-cell and B-cell infiltration across a compromised blood-brain barrier. This aberrant immune response orchestrates multifocal inflammatory cascades that p...